Source: Annual Congress 2004 - Genetics and immunology of tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. Phillips, R. N. Cataneo, R. Condos, G. A. Ring Erickson, J. Greenberg, V. La Bombardi (Fort Lee, Valhalla, New York, Woodinville, United States Of America). Volatile markers of pulmonary tuberculosis in the breath. Eur Respir J 2004; 24: Suppl. 48, 2924

Member's Comments

No comment yet.

Related content which might interest you: Volatile organic compounds in the exhaled breath of young patients with cystic fibrosis Source: Eur Respir J 2006; 27: 929-936 Year: 2006 Sensors for detecting pulmonary diseases from exhaled breath Source: Eur Respir Rev, 28 (152) 190011; 10.1183/16000617.0011-2019 Year: 2019 Volatile organic compounds in exhaled breath are associated with exacerbations in children with asthma Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma Year: 2009 The role of galactomannan in exhaled breath condensate in detecting pulmonary aspergillosis in patients with exacerbated COPD Source: Annual Congress 2012 - Prognostic indices in respiratory infections Year: 2012 Analysis of semi-volatile organic compounds in exhaled breath condensate of patients with obstructive lung diseases Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 Detecting active pulmonary tuberculosis with a breath test using nanomaterial-based sensors Source: Eur Respir J 2014; 43: 1522-1525 Year: 2014 Volatile organic compounds in exhaled breath of patients with COPD ± lung cancer and their correlation with FEV1-values Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Volatile organic compounds (VOC) in exhaled breath of patients with COPD Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases Year: 2010 Exhaled breath condensate markers in patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 334s Year: 2005 Correlation between lung function and exhaled breath condensate biomarkers of inflammation in pulmonary diseases Source: Annual Congress 2009 - Lung function in adults and children Year: 2009 Value of exhaled volatile organic compounds in monitoring airway disease Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases Year: 2013 Inflammatory markers in the exhaled breath condensate from patients with pulmonary sarcoidosis: comparison with BALF Source: Eur Respir J 2006; 28: Suppl. 50, 353s Year: 2006 Exhaled breath CO and induced sputum in noninvasive assessment of COPD Source: Eur Respir J 2003; 22: Suppl. 45, 457s Year: 2003 Exhaled breath condensate biomarkers in COPD Source: Eur Respir J 2008; 32: 472-486 Year: 2008 Exhaled volatile organic compounds in idiopathic pulmonary fibrosis and disease progression Source: Virtual Congress 2020 – Biomarkers and mechanistic aspects of idiopathic pulmonary fibrosis Year: 2020 Detection and characterisation of extracellular vesicles in exhaled breath condensate and sputum of COPD and severe asthma patients Source: Eur Respir J, 58 (2) 2003024; 10.1183/13993003.03024-2020 Year: 2021